John L. Marshall, MD: Zolbetuximab is a drug that you probably don’t know the name of, but you’re going to soon. Though you may have heard of claudin 18.2. Now, that’s been in the literature for a ...

Many patients with IBS and other functional GI disorders experience fragmentation of care and incur high costs. Can a virtual multidisciplinary model be the solution?

Comparing outcomes for early and late drainage of malignant ascites. Background: Black individuals, including African Americans, experience a disproportionate cancer burden and exhibit the lowest ...

A new study reinforces the principle that "practice makes perfect" when it comes to complex GI cancer operations. Patients whose procedures for gastrointestinal malignancies were performed by a ...

The Administrative Core will provide for overall direction, coordination, and administration of the Case Gl SPORE, including oversight of the SPORE Executive Committee, SPORE Internal Advisory Board, ...